Colposuspension

Colposuspension is a surgical procedure used to treat cervical cancer in situ, also known as cervical intraepithelial neoplasia (CIN) 3. This minimally invasive procedure is typically performed as an outpatient under general anesthesia. The goal of colposuspension is to remove abnormal tissue from the cervix while preserving the surrounding healthy tissue.

The procedure begins with a colposcopy, a procedure that uses a magnifying instrument to examine the cervix and vagina for abnormal areas. Once the abnormal tissue is identified, the surgeon makes a small incision in the cervix and inserts a loop electrosurgical unit (LESU) to remove the abnormal tissue. The LESU uses electrical current to cauterize and remove the tissue, sealing the blood vessels to control bleeding.

After the abnormal tissue is removed, the surgeon may perform a biopsy to confirm the diagnosis. If the biopsy results are negative, the procedure is complete. If the biopsy results are positive, the surgeon may recommend additional treatment, such as loop electrosurgical excision procedure (LEEP) or cone biopsy.

Colposuspension has several advantages over other treatment options. It is a minimally invasive procedure, which means it causes less discomfort and has a shorter recovery time. It also allows for immediate visualization of the cervix, which can help guide further treatment if necessary. However, colposuspension is not suitable for all patients with cervical cancer in situ. It is typically reserved for patients with low-risk lesions who are not candidates for more aggressive treatments.

As with any surgical procedure, colposuspension carries risks, including infection, bleeding, and damage to surrounding tissue. It is important for patients to discuss the potential risks and benefits with their healthcare provider before undergoing the procedure.